Replication of HIV-1 in vivo and in vitro

被引:27
|
作者
Orenstein, Jan Marc [1 ]
机构
[1] Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA
关键词
HIV; in vitro; in vivo; macrophage; TEM;
D O I
10.1080/01913120701344343
中图分类号
TH742 [显微镜];
学科分类号
摘要
A complex relationship exists between HIV and its cellular targets. The lethal effect of HIV on circulating CD4(+) helper T lymphocytes parallels the degree of the infected individual's immunodeficiency and ultimately the transition to AIDS and death. However, as with other members of the Lentivirus family of retroviruses, the ubiquitous, mobile macrophage is also a prime target for HIV infection, and apparently, in most instances, is the initial infected cell, since most people are infected with a CCR5 chemokine-tropic virus. Unlike the lymphocyte, the macrophage is apparently a more stable viral host, capable of a long infected life as an HIV reservoir and a chronic source of infectious virus. Published in vitro studies have indicated that whereas lymphocytes replicate HIV solely on their plasma membrane, macrophages have been envisaged to predominantly replicate HIV within cytoplasmic vacuoles, and thus have been likened to a "Trojan horse,'' when it comes to the immune system. Recent studies have revealed an ingenious way by which the cultured monocyte-derived macrophage (MDM) replicates HIV and releases it into the medium. The key macrophage organelle appears to be what is alternatively referred to as the "late endosome'' ( LE) or the "multivesicular body'' (MVB), which have a short and a long history, respectively. Proof of the association is that chemically, LE/MVB and their vesicles possess several pathopneumonic membrane markers ( e.g., CD63) that are found on released HIV particles. The hypothesis is that HIV usurps this vesicle-forming mechanism and employs it for its own replication. Release of the intravacuolar virus from the cell is hypothesized to occur by a process referred to as exocytosis, resulting from the fusion of virus-laden LE=MVB with the plasma membrane of the macrophage. Interestingly, LE=MVB are also involved in the infection stage of MDM by HIV. Close review of the literature reveals that along with the Golgi, which contributes to the formation of LE=MVB, the MVB was first identified as a site of HIV replication by macrophages many years ago, but the full implication of this observation was not appreciated at the time. As in many other areas of HIV research, what has been totally lacking is an in vivo confirmation of the in vitro phenomenon. Herein, the ultrastructure of HIV interaction with cells in vitro and in vivo is explored. It is shown that while HIV is regularly found in LE=MVB in vitro, it is infrequently the case in vivo. Therefore, the results challenge the "Trojan horse'' concept.
引用
收藏
页码:151 / 167
页数:17
相关论文
共 50 条
  • [1] Effect of GM-CSF on HIV-1 replication in monocytes/macrophages in vivo and in vitro: A review
    Kedzierska, K
    Rainbird, MA
    Lopez, AF
    Crowe, SM
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 63 (1-2) : 111 - 121
  • [2] Synergistic inhibition of HIV-1 reverse transcriptase and HIV-1 replication by combining trovirdine with AZT, ddl and ddC in vitro
    Zhang, H
    Vrang, L
    Rydergard, C
    Ahgren, C
    Oberg, B
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1996, 7 (05): : 221 - 229
  • [3] μ-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication
    Steele, AD
    Henderson, EE
    Rogers, TJ
    VIROLOGY, 2003, 309 (01) : 99 - 107
  • [4] Anti-gene peptide nucleic acid targeted to proviral HIV-1 DNA inhibits in vitro HIV-1 replication
    Pesce, CD
    Bolacchi, F
    Bongiovanni, B
    Cisotta, F
    Capozzi, M
    Diviacco, S
    Quadrifoglio, F
    Mango, R
    Novelli, G
    Mossa, G
    Esposito, C
    Ombres, D
    Rocchi, G
    Bergamini, A
    ANTIVIRAL RESEARCH, 2005, 66 (01) : 13 - 22
  • [5] Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication
    M. M. Prokofjeva
    N. N. Orlova
    A. S. Gornostaeva
    A. A. Shulgin
    N. A. Nikitenko
    V. N. Senchenko
    T. D. Lebedev
    P. V. Spirin
    K. Riecken
    B. Fehse
    C. Stocking
    V. S. Prassolov
    Molecular Biology, 2014, 48 : 297 - 300
  • [6] Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication
    Prokofjeva, M. M.
    Orlova, N. N.
    Gornostaeva, A. S.
    Shulgin, A. A.
    Nikitenko, N. A.
    Senchenko, V. N.
    Lebedev, T. D.
    Spirin, P. V.
    Riecken, K.
    Fehse, B.
    Stocking, C.
    Prassolov, V. S.
    MOLECULAR BIOLOGY, 2014, 48 (02) : 297 - 300
  • [7] INHIBITION OF HIV-1 REPLICATION BY DAUNORUBICIN
    FILION, LG
    LOGAN, D
    GAUDREAULT, R
    IZAGUIRRE, CA
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1993, 16 (05): : 339 - 347
  • [8] Immune stimulation and HIV-1 viral replication
    Wahl, SM
    Orenstein, JM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (01) : 67 - 71
  • [9] Cellular specificity of HIV-1 replication can be controlled by LTR sequences
    Reed-Inderbitzin, E
    Maury, W
    VIROLOGY, 2003, 314 (02) : 680 - 695
  • [10] Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System
    Prokofjeva, M. M.
    Spirin, P. V.
    Yanvarev, D. V.
    Ivanov, A. V.
    Novikov, M. S.
    Stepanov, O. A.
    Gottikh, M. B.
    Kochetkov, S. N.
    Fehse, B.
    Stocking, C.
    Prassolov, V. S.
    ACTA NATURAE, 2011, 3 (04): : 55 - 65